20-24 June, 2026 Kuala Lumpur
| 3-P | Are indicators used to evaluate low- and middle-income country progress in transfusion medicine the right ones? | Cees Smit Sibinga | |
| 5-P | Transfusion Service–Led Coordination Pathway for Patients with Suspected IgA Deficiency Across Two Hospitals and Blood Centres | Rishiraj Sinha | |
| 7-P | "Evaluating Transfusion Appropriateness and Safety: A Year-Long Audit of Blood Component Therapy in a Tertiary Care Hospital in Dhaka" | Sonia Shormin Miah | |
| 8-P | Retrospective Analysis of Manual Verification with the Tube Method following Automated ABO Blood Grouping in a Korean University Hospital: Toward Establishing an Efficient Stepwise Testing Protocol | Jeong Won Shin | |
| 16-P | Validation of the requirement for the investigation of the discrepancy results between Pilot Tube Serology and Blood Bag donation | Norshuhaidah Jamaludin | |
| 22-P | Low-cost system redesigns using human-factor principles to improve safety in a resource-limited blood centre like Shisa Kanko | Arun V J | |
| 24-P | Triple versus Double Blood Bag Systems – Cost, Waste, and Carbon Emission: Impact Analysis in a Single Regional Blood Center in the Philippines | Sherjan Pangato | |
| 28-P | From one hospital to a health system: Rapid scale-up of functional hospital transfusion committees in Cameroon | BEUKOU FONKOU HYGIN STEVE | |
| 35-P | Training Needs Assessment for Transitioning from Cesium-137 to X-ray Blood Irradiators in African Countries | Mostafa Kofi | |
| 41-P | Capacity Gaps, Accreditation, and Predictions for African Blood Banking Professionals (2026–2040) | Mostafa Kofi | |
| 42-P | Standardization Gaps and Workforce Competencies Among Blood Banking Professionals in Africa: A Continental Systems Analysis | Mostafa Kofi | |
| 50-P | Risk-based implementation model with sequential auditable critical milestones to standardize technology transitions in a high-complexity university hospital blood bank | Erika Milena Granados Ferrer | |
| 63-P | A retrospective analysis of the antigen-negative red blood cell supply conducted at a single center in China | Aiping Zhao | |
| 65-P | Utilisation and Inventory Challenges of Group O RhD-Negative Red Cell Units in a Secondary Hospital: Experience from Taiping Hospital, Malaysia | Nurulraihan Mohamed Zawawi | |
| 67-P | Strategy for Precision Blood Supply for Transfusion-dependent Thalassemia Patients | Hsiao-Fen Chen | |
| 69-P | Interinstitutional perspectives on usage of fibrinogen concentrates and cryoprecipitate | Cindy Tay | |
| 70-P | Blood supply and covid-19: disaster or blessing in disguise? | Cees Smit Sibinga | |
| 71-P | Audit of Blood Supply and Utilization in a Hospital Blood Bank | Hannah Olawumi | |
| 81-P | Guideline dissemination and blood component utilization in Japanese hospitals | Shinichiro Fujiwara | |
| 99-P | Facility-Level Disparities in Blood Grouping Serology EQA Performance: Descriptive Analysis year 2024 from Tanzania | Don-Dolcetto Ngilisho | |
| 100-P | TRACE-PNG: Uncovering the hidden burden of red cell exposure and missed opportunities for antibody screening in Papua New Guinea. | Natasha Philip | |
| 114-P | Innovative Application of RFID-Based Intelligent Closed-Loop Management in Automated Blood Specimen Handover | Jie Zhao | |
| 119-P | Strengthening transfusion safety in a resource-limited blood centre through stepwise donor screening audit and sustained quality improvement | ARUN V J | |
| 120-P | Life Cycle Assessment (LCA) of Macopharma´s SSP4025U SSP+ Reference: A Step Toward Sustainable Practices | Quentin Brebant | |
| 124-P | Evaluation and Improvement Strategy of Laboratory Turnaround Time of Group, Screen & Hold in Tertiary Care Teaching Hospital in Malaysia | Khalid Zalizah | |
| 136-P | Disaster response to the Tai Po Fire – a reflection of the roles and responsibilities of Blood Transfusion Service to meet public expectation | Shun Yin Kong | |
| 137-P | Public and stakeholder perspectives on ethical innovation beyond transfusion: A mixed methods PPIE study of human platelet lysate within the blood supply chain | michael.cahillane@wales.nhs.uk Cahillane | |
| 138-P | Understanding beliefs Aboriginal and Torres Strait Islander Peoples have about blood donation and blood transfusion for Culturally Safe provision of blood services | Maree Perry | |
| 140-P | I hope it would be available to anybody who needs it: Exploring donor perspectives on laboratory-grown red blood cells | Rachel Thorpe | |
| 143-P | Accepting blood donors for source plasma with no sexual activity restrictions; the world first Australian experience of the first six months post implementation | Anthea Cheng | |
| 148-P | From hesitation to participation: Impact of educational and motivational interventions on voluntary blood donation among medical students in Pakistan | Fahad Ahmed | |
| 160-P | Optimization of the Donor Selection Process Using a Real-Time Support Channel and Its Impact on Deferral Reduction | Michel-Andres Michel-Andres | |
| 172-P | Perception of Blood Donation Among Medical Students | Michel-Andres Garcia-Otalora | |
| 174-P | Comparative Evaluation of Point-of-Care Hemoglobin and Hematocrit Measurement Devices Using Venous Blood Samples | Christopher Pöhlmann | |
| 177-P | Missed Opportunities in Blood Donation: Donor Deferral Experience from Taiping Hospital, Malaysia | Nurulraihan Mohamed Zawawi | |
| 178-P | Addressing the Youth Blood Donor Challenges: Effectiveness of Pop Culture Integration in Blood Donation Campaigns in Singapore | Nurliana Omar | |
| 179-P | Research on factors influencing voluntary non-remunerated blood donors satisfaction based on grounded theory | Tingting Hu | |
| 185-P | Beyond blood donation camps: using community engagement programs to improve blood collection and donor retention | Mohd Redzuan Abdullah | |
| 186-P | Effect of virtual reality during blood donation on donor mood states: a pilot study using the BRUMS scale | ARUN V J | |
| 191-P | "Pop-up" blood donation sites in urban shopping malls as an option to recruit younger donors in urban areas and to ameliorate demographic challenges | Lambros Kordelas | |
| 196-P | Blood Donor Recruitment and Retention Analysis: A Five-Year Strategic Review (2021-2025) | Khairawati Binte Harip | |
| 198-P | Eighty-five percent non-return following low haemoglobin deferral as a silent threat to transfusion sustainability in Colombia | Michel-Andres Garcia-Otalora | |
| 200-P | From Donors to Co-Creators: Redesigning the Blood and Plasma Donation Experience Through Human-Centered | Nuria Nogues | |
| 201-P | Deferral of blood donors in the colombian caribbean region between 2017 and 2023: a contrast with the national average | Michel-Andres Garcia-Otalora | |
| 202-P | LGBTQ+ affiliated blood drives engage younger, more diverse, and first-time blood donors | Waseem Anani | |
| 203-P | Impact of Gift Provision on Six-Month Return Rates Among Blood Donors | SHARMILA MANIAN | |
| 206-P | Mapping Donor Trajectories in Blood and Plasma Donation: Predictive Modeling and Explainable Insights for Retention Strategies | Nuria Ribas | |
| 209-P | Performance evaluation of blood donor selectors in Colombia: Is the process aligned with the national technical guideline? | Michel-Andres Garcia-Otalora | |
| 210-P | Fostering a culture of donation with African, Caribbean, and Black communities | Jennie Haw | |
| 219-P | Iron deficiency and plateletpheresis associated lymphopenia increase with donation frequency in plateletpheresis donors | April Davis | |
| 224-P | Therapeutic Venesection as a Core Treatment Strategy for Polycythemia and Iron Overload Disorders: A Single-Center Experience | Ayat Osman | |
| 240-P | Prevalence of Elevated Haemoglobin Levels Among Blood Donors in Singapore: A Three-Year Retrospective Analysis (2023–2025) | Kyi Kyi San | |
| 242-P | Hemovigilance Trends and Donor Satisfaction in Mobile Plasmapheresis: Outcomes from a Decentralized Collection Program | Nuria Ribas | |
| 246-P | Iron status of first time and repeat blood donors in Ibadan, Nigeria | Foluke Fasola | |
| 249-P | Iron supplementation for whole blood, red cell, and plasma donors, to reduce deferral and anaemia. | Susan Brunskill | |
| 252-P | The Outcomes of Female Blood Donation Campaign in North Al Sharqiya, Oman: A Prospective Analysis | Musleh Al Musalhi | |
| 254-P | Exploring preferences of blood donors with high ferritin for genetic testing through blood donation | Rachel Thorpe | |
| 259-P | Analysis of Latent Iron Deficiency Among Blood and Blood Component Donors | Ala Novik | |
| 261-P | Uplifting pre-donation haemoglobin cutoff from 11.5 to 12 g/dL for female blood donors in Hong Kong – a tectonic change in practice with over 50 years of history | Shun Yin Kong | |
| 265-P | Donor Voices, Future Choices: A Cross-Sectional Descriptive Survey Understanding the Willingness for Allogeneic Leukapheresis Donation Amongst Lifeblood Donors | Justine ODonovan | |
| 273-P | Qualitative Feedback from Plasma Donors on the Methodology of a Future Prospective Cohort Study | Michelle Fransen | |
| 275-P | IT-based active surveillance system for apheresis collections | Marcia Cardoso | |
| 277-P | Risk factors for citrate–induced paresthesia in apheresis donors | Manuel Gutiérrez de Ravé | |
| 285-P | Safety of Apheresis Donation Compared to Whole Blood Donation in Singapore | Grace Kam | |
| 286-P | Analytical performance evaluation of a multiplexed serology assay designed to support a nationwide repeat blood donor based respiratory virus serosurveillance program | Marion Lanteri | |
| 288-P | Per- and polyfluoroalkyl (PFAS) concentrations in high and low frequency donors | Ole Birger Pedersen | |
| 289-P | Surveillance of respiratory virus infections using surveys of a cohort of United States blood donors initiated in 2025 | Bryan Spencer | |
| 292-P | Longitudinal Serological Surveillance Identifies Recurrent SARS-CoV-2 and other Respiratory Virus Infections in Frequent Plasma Donors | Clara Di Germanio | |
| 293-P | Metabolic risk screening in adolescent blood donors. | Stephen Eason | |
| 298-P | Three-Buffy-Coat Pooled Platelet Concentrates: Establishing Clinical Functionality, Yield Compliance and Inventory Benefits in Routine Manufacture from a Welsh Perspective | Michael Cahillane | |
| 301-P | Blood compatibility and safety performance of a plasticiser-free SEBS/PP blood bag material | Srimala Sreekantan | |
| 303-P | Impact of Weekly Mixing of Red Cell Concentrates on Storage Quality: A Comparative Study | Anaïs LAGRANGE | |
| 304-P | ´Method Validation and Quality Control Comparison of Blood Components Prepared by Inline Filtration Versus Fully Automated Processing´ | Pavarit Arayasukawat | |
| 307-P | In vitro quality of x-ray irradiated RBCs in PAGGS-M prepared in non-DEHP bag systems | Ute Gravemann | |
| 335-P | Assessing the quality of apheresis-derived red cell concentrates stored in AS-3 additive solution | Marcia Cardoso | |
| 337-P | Standardization of the Romanian Blood Transfusion Services— Deployment of whole blood automation | Marcia Cardoso | |
| 339-P | Quality Monitoring of Blood Components: Descriptive Analysis and Standard Comparison at a Tertiary care hospital blood center, Sri Lanka | Trileeshiya Withanawasam | |
| 343-P | Evaluation of an Analyzer with Blood Bank Mode for Counting Residual Red Blood Cells in Plasma and Platelet Components Prior to Pathogen Inactivation | Lidice Bernardo-Reyes | |
| 350-P | In vitro evaluation of Red Cell Concentrates, Platelets recovered pooled and Plasma prepared and stored in non-DEHP bags from whole blood collected in full non-DEHP In-Line system | Laurent Aoustin | |
| 351-P | Evaluation of Pooled Buffy Coat Platelets Stored in SSP+ PAS : Experience at the Institute for Blood Transfusion of Montenegro | Jelena Zonji&263; | |
| 354-P | ABO Blood Group Influences Baseline Clotting Kinetics but Not Storage Stability of Apheresis Platelets | Susan Shea | |
| 355-P | Lessons learned from a systematic review of lab (in vitro) studies – possible improvements in the reporting of laboratory-based studies | Catherine Kimber | |
| 361-P | Safety of autologous fibrin glue production using the CryoSeal system | Mai Matsubara | |
| 362-P | The majority of male blood donors of blood group A show low or very low anti B-titer which are mostly stable during a follow-up period of one year | Lambros Kordelas | |
| 377-P | Integration of Pathogen Reduction Technology into Operational Plasma Production: An Innovative Approach to Plasma Pooling | Roya Pasha | |
| 379-P | Differences in the effects of HIF-PHI due to gender differences in CKD with renal anemia | AKIRA MIMA | |
| 382-P | Downscaling to small-volume storage bags supports platelet quality and efficient use of cold-stored platelets for preclinical studies. | Janhavi Mahajan | |
| 388-P | A Novel Supercritical CO2-Modified Leukoreduction Filter with Enhanced Microparticle Removal | Yong-Guei Chen | |
| 390-P | Antioxidant-Loaded Nanomaterials For Extending Red Blood Cell Shelf Life | Afnan Jabr Alsulami | |
| 391-P | Agitation induces aggregate formation in cold-stored platelets during extended storage in platelet additive solution. | Janhavi Mahajan | |
| 395-P | Human platelet lysate from time-expired pooled platelet concentrates: Sustainable manufacture, quality, growth-factor mechanisms and functional relevance towards standardised blood-service supply | Michael Cahillane | |
| 396-P | Key Baseline Parameters May Predict Cold-Stored Platelet Function at 21 Days | Susan Shea | |
| 408-P | Re-entry of donors deferred for false-reactive screening tests in Canada: 10 years post-implementation | Sheila OBrien | |
| 415-P | Characteristics of Human Parvovirus B19 Infection in Blood Donors in Lanzhou, China, 2022–2023 | Kangle Wu | |
| 419-P | Risk-Based Donor Deferral Does Not Increase Infectious Marker Reactivity: Evidence from Colombian Blood Banks (2018–2024) | Michel-Andres Garcia-Otalora | |
| 444-P | Evaluation of an enhanced-sensitivity HBsAg assay for donor screening across three Latin American blood services | Guillermo Andres Orjuela | |
| 447-P | Frequency and trends of Hepatitis B & C, and human immune deficiency virus in blood donors presenting to blood bank of a Tertiary Hospital in Peshawar, Pakistan. | Neelam Ahmad | |
| 453-P | Data driven, phased, cost-adaptive blood donor hepatitis B virus (HBV) screening strategy for low-middle income countries (LMICs): Aligning with international standards under funding constraints | Rabia Majeed | |
| 456-P | Can Social Media Convert Engagement into Donation? A Data-Driven Recruitment Model from Kuwait Blood Bank | Eman Monir | |
| 464-P | PREVALENCE OF HIV, SYPHILIS, HEPATITIS B AND C IN A REGIONAL BLOOD BANK IN A TERTIARY GOVERNMENT HOSPITAL IN EASTERN VISAYAS | Kristine Joy Abordo Gacutno | |
| 466-P | Estimating the residual risk of HIV, HBV, and HCV in blood transfusion: a comparison of calculation methods in an upper-middle-income Latin American country | Jean Stanley | |
| 467-P | Residual risk of transfusion-transmitted HIV, HBV and HCV with NAT screening in Colombia, Honduras and Argentina: application of a novel method for estimating incidence in blood donors | Jean Stanley | |
| 469-P | Assessing the cost-effectiveness of screening blood donations for HEV | Igor Rossa-Ramm | |
| 470-P | Assessment of HIV pre-exposure prophylaxis and antiretroviral therapy use in Brazilian blood donors | Renata Buccheri | |
| 476-P | Impact of Bacterial Screening Implementation on Medical Institutions: Analysis of In-Hospital Operations and Supply Chain Challenges | Tadashi Matsushita | |
| 481-P | Transfusion-Transmitted Malaria in India: A National Survey of Epidemiology and Associated Blood Donor Screening Practices | Evan Bloch | |
| 482-P | Blood donor Babesia Nucleic Acid Test Surveillance in Nova Scotia, Canada: 2025 | Steven Drews | |
| 483-P | Sentinel surveillance of asymptomatic malaria among blood donors in a malaria endemic region in India : implications for malaria elimination | Girish Singh Kshatriya | |
| 484-P | Malaria parasitemia may be associated with false positive copper sulfate test in blood donor anaemia screening | Foluke Fasola | |
| 485-P | Plasmodium parasitemia in standard platelets concentrates at Yaounde Central Hospital | Hortense Ngegni Pangetna | |
| 495-P | The impact of the 2025 Chikungunya outbreaks in France and Italy on donor management in Switzerland | Sandra Kurth | |
| 497-P | Infectious syphilis in Canadian blood donors | Sheila OBrien | |
| 507-P | Procedural factors affecting interlaboratory variability in anti-blood group antibody titration based on proficiency testing data | Jiwoo Lee | |
| 508-P | Anti-Sda: When Pan-reactivity Without Clinical Significance | Gowri Ganason | |
| 516-P | Comparison of ABO group and Rh Phenotype between Sickle Cell Disease Patients and General Donor Population in North Al Sharqyia Region, Oman. | Musleh Al Musalhi | |
| 519-P | Redefining Anti-A1: Clinically Significant ABO Discrepancies in Three A2 Patients | Dhargam Aljebouri | |
| 520-P | Cold Autoanti-IH : Immunohematologic Behavior and Clinical Relevance by Antigen Density | Dhargam Aljebouri | |
| 521-P | A Study Of Clinical Correlation Of Direct Coombs Test In A Referral Blood Bank | Muhammad Faisal | |
| 525-P | An Algorithm with Rule-Out Assistance for Antibody Identification | David Mongin | |
| 526-P | Enhanced automated antibody titration: field evaluation and statistical equivalence analysis versus manual gel methodology | Jessica Payne | |
| 527-P | Phenotypic Distribution of ABO, Rh and Kell-1 Blood Group Antigens among 3,090 Iraqi Blood Donors: Implications for Transfusion Practice | Yaqoob Almusawi | |
| 535-P | Specificity and Prevalence of Red Blood Cell Alloantibodies among Patients in Latvia | Solvita &268;er&326;avska | |
| 538-P | Multi-center clinical assessment of a neutral gel matrix card for ABO reverse grouping: performance and matrix equivalence | Jessica Payne | |
| 542-P | The rare that matters: managing Bombay blood group in obstetric emergency | arif azhar | |
| 543-P | Appraisal of blood grouping difficulties, antibody specification and titration, among the patients with Cold Agglutinin Disease in a tertiary care hospital, Bangladesh | Sonia Shormin Miah | |
| 545-P | Analysis of the dynamics of alloimmunization to red blood cell antigens from 2008 to 2025 | Irina Krobinets | |
| 550-P | Prevalence of red blood cell antibodies among patients in Peninsular Malaysia: a retrospective observational study at four major referral tertiary care hospitals | Pei Pei Tan | |
| 571-P | Prevalence of Anti Mia antibody among patients admitted at Hospital Sultan Ismail, Johor Bahru | THAENUJAH NAIR RAMACHANDRAN | |
| 573-P | Rh Phenotype Distribution Among Blood Donors in a Multi-Ethnic Malaysian Population: Experience from Taiping Hospital, Perak, Malaysia | Nurulraihan Mohamed Zawawi | |
| 579-P | Analytical performance and comparative evaluation of papain-treated 0.8% reagent red blood cells for antibody identification using gel technology | Jessica Payne | |
| 591-P | Determination of Anti-A and Anti-B Titers in blood donors using automation in Northern Taiwan | Shu-Hui Feng | |
| 596-P | CROSS-MATCH POSITIVE BLOOD TRANSFUSION-CASE REPORT | Tatjana Makarovska Bojadzieva | |
| 605-P | Reagent Red Blood Cell Production: The Crucial Partnership Between Donor Center and Manufacturers | Michelle Mullens | |
| 608-P | The forgotten XG blood group system: a case of anti-Xga alloimmunisation | Mohd Redzuan Abdullah | |
| 611-P | Recovery and phenotyping of autologous red blood cells in recently transfused patients :A feasibility study | V AISHWARYA | |
| 618-P | Auto Anti-B - a rare occurrence found in a Patient with CD5-/CD10- Small B-cell Lymphoproliferative Disorder. A Case Report from a Local Tertiary Hospital. | Ting Yi Tan | |
| 625-P | Investigation of a commercial monoclonal anti-D typing reagent as a potential quality control reagent in the monocyte monolayer assay | John-Paul Tung | |
| 627-P | Enzyme-Assisted Identification of Multiple Red Cell Alloantibodies Under Resource Constraints | Dilini Ranasinghe | |
| 639-P | An A3subgroup presenting as ABOdiscrepancy in a newly diagnosed leukemia patient a diagnostic challenge | Subash Sadanandan | |
| 653-P | Analytical performance and repeatability of a neutral gel card for reverse ABO grouping across manual and automated platforms | Jessica Payne | |
| 654-P | Analytical performance and Rh variant detection using gel-based Rh phenotyping cards across automated and manual platforms | Jessica Payne | |
| 655-P | Multisite precision and clinical method comparison of 3% reagent red blood cells for reverse ABO grouping using the tube method | Jessica Payne | |
| 658-P | Large-scale multi-center clinical evaluation of a column agglutination technology for Rh phenotype (C, c, E, e) determination | Jessica Payne | |
| 663-P | Challenges in Detecting Anti-CD36 as a red blood cell Antibody within the Japanese Screening System | Toru Miyazaki | |
| 669-P | Geographic boundary for the Asian-type DEL in South Asia | willy (bill) albert flegel | |
| 670-P | "THE ROLE OF ABO BLOOD GROUP SYSTEM IN THE OCCURRENCE OF VENOUS THROMBOEMBOLISM" | Elena Ristovska | |
| 674-P | Identification of three novel LAN null alleles | Louise Tilley | |
| 676-P | From donor genotype to patient care: fifteen years of donor genotyping to build a rare blood inventory and enable precision transfusion support | Christine Henny | |
| 677-P | Extended genotyping of blood donors by next generation sequencing | Daniel Fürst | |
| 681-P | Study on the serological characteristics and molecular biological analysis of samples mistyped as O phenotype | Yuwan Dai | |
| 683-P | Identification and Functional Characterization of a Rare ABO Allele Carrying the c.280A>T Variant Associated with a Weak A Phenotype | Qi Liu | |
| 688-P | Identification of three new JR null alleles by serological and genetic analyses | Vanja Karamatic Crew | |
| 690-P | Two new FUT1 alleles resulting in H-deficient red cell phenotypes | Louise Tilley | |
| 692-P | Serological and molecular investigation of a case of the In(Lu) phenotype with a novel genetic background, discovered incidentally during an antibody investigation | Vanja Karamatic Crew | |
| 693-P | A novel p.Met52Arg substitution in ICAM-4 causes a serological LW null phenotype | Nicole Thornton | |
| 697-P | Bioinformatics Analysis of RHD1227A DEL Asian-Type Protein: Sequence, Structure, and Functional Characteristics | Dandan Han | |
| 698-P | Discrepant serologic RhC typing using different methods and the underlying molecular genetic background | Elke Weinig | |
| 700-P | Detection of D Variants in Kuwait by Molecular Genotyping Using Fluorescence Based Real Time PCR | Amna Al-Shemmari | |
| 708-P | Performance Evaluation of a Red Cell Sequencing Kit for Accurate Blood Group Genotyping | ROZI HANISA MUSA | |
| 715-P | Blood group profile of Japanese population: Analysis based on whole genome database | Masamichi Mikame | |
| 733-P | Rare anti-hrs alloimmunization in a DAR-ceAR pregnant woman: the vital synergy between hospital screening and reference molecular diagnostics | Barbara Baluce | |
| 740-P | Comparative analysis of MAIPA and PakLx for detection of platelet-specific alloantibodies: implications of assay limitations | Klara Asplund Högelin | |
| 749-P | Prevalence of Human Leucocyte Antigen (HLA) Antibodies in Platelet Transfusion Refractoriness: Experience from National Blood Centre, Malaysia | Puteri Sollehah Azlan | |
| 756-P | Optimising HLA-Selected Platelet Provision in Wales Through Targeted Recruitment from the Welsh Bone Marrow Donor Registry | Kalinga Perera | |
| 761-P | Investigating the Association Between anti-Human Leukocyte Antigen (HLA) Antibodies and Fetal and Neonatal Alloimmune Thrombocytopenia | Shoma Baidya | |
| 766-P | Fetal and neonatal alloimmune thrombocytopenia - A case report | Angelina Cvijovi&263;-Ranitovi&263; | |
| 767-P | Primary Anti-D Alloimmunization in a Nulliparous Woman: From Recurrent Hydrops Fetalis to Preventive Embryo Selection | Dhargam Aljebouri | |
| 772-P | Clinically Significant Anti-M in Pregnancy: The Important Role of Transfusion Medicine in Multidisciplinary Care | Muhammad Noor Haziq Ibrahim | |
| 794-P | Intrauterine Transfusion in a Foetus with Homozygous Southeast Asian Ovalocytosis: A Case Report | Khui Yie Chew | |
| 795-P | A comparative analysis between Retrograde Autologous Blood Priming (RAP) versus Allogenic Blood Priming in Cardio-Pulmonary Bypass circuits during Pediatric Cardiac Surgery | DEBASISH GUPTA | |
| 798-P | When Rare Blood Meets Limited Resources: Transfusion Challenges in a JK-Null HbE ß-Thalassaemia Patient | Nur Syafika Atia Muktar | |
| 799-P | Evaluation of Packed Red Blood Cell Utilization and Appropriateness in a Pediatric Tertiary Care Cohort: A Five-Year Retrospective Audit | Amit Ajay Pawar | |
| 802-P | A lack of scientific evidence and consensus leads to significant variation in massive transfusion protocols used to treat massive hemorrhage in children and neonates across Dutch university hospitals | Elise Huisman | |
| 805-P | A Rare Presentation of Vitamin B12 Deficiency: Severe Macrocytic Anemia, Thrombocytopenia, and Intramedullary Hemolysis | Vanessa Oliveira | |
| 806-P | A Case Report : Glanzmann Thrombaesthenia in Obstetrics Patient in Penang District Hospital, Malaysia : Transfusion Management | Faezah Fauzi | |
| 815-P | APPLICATION OF PLASMA EXCHANGE IN THE TREATMENT OF THROMBOTIC THROMBOCYTOPENIC PURPURA - A RETROSPECTIVE SINGLE CENTER STUDY | Bin Zhang | |
| 820-P | Comprehensive Age-based Assessment of Thrombotic Thrombocytopenic Purpura: Clinical and Laboratory Features, Treatment Patterns, and Outcomes | Nour AlMozain | |
| 823-P | Capecitabine-Associated Thrombotic Microangiopathy with Evidence of Terminal Complement Activation in Metastatic Breast Cancer | Nour AlMozain | |
| 824-P | Results of GVHD treatment with various modifications of extracorporeal photopheresis | Irina Kumukova | |
| 826-P | Safety and Efficacy of Apheresis in Children: A Comparative Study of Therapeutic Leukoreduction in Severe Pertussis Infants versus PBMC Collection in Healthy Pediatric Donors | Yixin Gao | |
| 838-P | Analysis of Electronic Positive Patient Identification (ePPID) Mismatch Alerts at a Large Academic Hospital (2017–2024) | Widad Abdulwahab | |
| 839-P | Transfusion Outcomes in Platelet Transfusion Refractoriness Patients Receiving Crossmatch-compatible Platelets: Study in Malaysian Hospitals | Muhammad Noor Haziq Ibrahim | |
| 849-P | The association of blood Transfusion and medical resources utilization in Palliative Care for Sepsis | Ju-Huei Chien | |
| 854-P | Utilisation Pattern of Apheresis Platelets in a Secondary Hospital: A Five-Year Experience from Taiping Hospital, Malaysia | Nurulraihan Mohamed Zawawi | |
| 856-P | Development and Evaluation of an Innovative Screening Tool for Heavy Menstrual Bleeding in Female Blood and Plasma Donors: A Validation Study | Su Someh | |
| 861-P | Knowledge and Practices of Blood Transfusion and Patient Blood Management (PBM) Among Medical Officers in Hospital Rembau | MUGUNTHAN M. SATHIVAL | |
| 862-P | Multidisciplinary consulting meeting for complex transfusion in sickle cell disease: a 4-year review in France | France Pirenne | |
| 863-P | Clinical agreement and prognostic implications of ADAMTS13 activity in thrombotic microangiopathy: automated chemiluminescent immunoassay versus ELISA | Susung Kim | |
| 864-P | Transfusion Evidence RoundUps and the Talking Transfusion Podcast: a collaboration to enhance outcomes for patients and donors by increasing the dissemination of the transfusion medicine evidence base | Susan Brunskill | |
| 867-P | Malignancies diagnosed in blood donors: three case histories and the implications for transfusion safety | Kalinga Perera | |
| 868-P | Efficiency and Safety Gains from Bedside Electronic Transfusion Checks in four hospitals in England | Florence Oyekan | |
| 870-P | Prolonged continuous platelet infusion in refractory hemato-oncological patients with bleeding or high hemorrhagic risk: a single-centre experience | Andrei Kolesov | |
| 871-P | Staff satisfaction with the use of Bedside Electronic Transfusion Checks at three hospitals in London | Florence Oyekan | |
| 872-P | Clinical Benefits of Bedside Electronic Transfusion Checks – A before and after comparative study | Josephine McCullagh | |
| 875-P | A Comparative Study of Irradiated versus Non-irradiated Platelet Transfusion in Liver Transplantation: No Adverse Impact on Perioperative Recovery and Graft Function | Li He | |
| 882-P | Transfusion-Associated Hyperkalemia Following Transfusion of Irradiated Red Blood Cells in Massive Transfusion: Two Case Reports and Quality Audit Analysis | Ghadah Alyami | |
| 894-P | ROTEM Profiles in Patients Requiring Massive Transfusion Protocol: A Tertiary Hospital Experience | Muhammad Noor Haziq Ibrahim | |
| 895-P | Massive transfusion patterns and group O RhD-negative red blood cell inventory in the Capital Region of Denmark, 2007–2022 | Martin Vigstedt | |
| 900-P | Review of Massive Haemorrhage Protocol Activations at a Major Trauma Centre | David Roxby | |
| 901-P | Adherence to ROTEM-Guided Transfusion During Massive Transfusion Activation: A Retrospective Analysis from a Tertiary Centre in South Australia | David Roxby | |
| 902-P | The Silent Struggle: Overcoming Heparin Resistance and ECMO Support in CABG | NOOR BINTI ASHAMUDDIN | |
| 906-P | Value of Baseline Prothrombin Time (PT%) in Predicting Clinical Outcomes and Transfusion Burden in VA-ECMO Patients | Thanh Nguyen Chi | |
| 911-P | Probable TRALI Type II in a Pediatric Patient with Biliary Atresia and Asthma: A Case Report | SHARMILA MANIAN | |
| 912-P | TRALI Type I Following Red Cell Transfusion from a Donor with Multi-Specific Anti-HLA Antibodies: A Case Report | Nithiyaa Bala | |
| 914-P | Transfusion-Associated Circulatory Overload (TACO) in Cardiac Surgery: An Underrecognized Clinical Challenge | Almedina Spiljak | |
| 918-P | A rare case of a healthy young woman, developing hyperhaemolysis after erythrocyte transfusion. | Kathrine Johnsen | |
| 923-P | Transfusion Reactions Associated with Hematopoietic Stem Cell Infusions from Female Donors: A Retrospective Pediatric Study | FATMA BURCU BELEN APAK | |
| 924-P | Anti-human neutrophil antigen antibody mediates post-transfusion severe neutropenia | Sheng-Hsuan Chien | |
| 926-P | Multidimensional exploratory data analysis of pulmonary transfusion reactions reported to SHOT | tom Latham | |
| 928-P | The Incidence of anti-IgA in patients with absolute deficiency or very low levels of Immunoglobulin A | Margaret Keller | |
| 932-P | Leukocyte Antibody Screening in Platelet Apheresis Donors: The Taiwan Experience | Ling-I Hsu | |
| 938-P | PROFILE OF LEAST INCOMPATIBLE TRANSFUSIONS IN ALLOIMMUNIZED PATIENTS: A RETROSPECTIVE STUDY IN INDONESIA | Betty Agustina Tambunan | |
| 940-P | Epidemiological Profile of Transfusion Reactions Since 2007 : Hemovigilance Data from La Rabta University Hospital, Tunis | Mayar Srairi | |
| 942-P | Near-Miss Events in Blood Transfusion at Taiping Hospital: A Three-Year Haemovigilance Review (2023–2025) | Nurulraihan Mohamed Zawawi | |
| 949-P | Human Factors Contributing to Transfusion Errors: Lessons from Taiping Hospital, Malaysia, a Hospital Haemovigilance System | Nurulraihan Mohamed Zawawi | |
| 951-P | Post-transfusion alloimmunization in allogeneic and autologous hematopoietic stem cell transplant recipients: incidence estimates and platelet-imputed reports | Aline MIRRIONE-SAVIN | |
| 953-P | Same name, same ward, wrong patient; a review of ABO-incompatible red cell transfusions due to collection errors | Nicola Swarbrick | |
| 955-P | Distinct profile of serious adverse events in haematopoietic stem cell transplant recipients: a 10-year national haemovigilance analysis | Aline MIRRIONE-SAVIN | |
| 961-P | Active hemovigilance in concurrent platelet-plasma apheresis: Insights into donor safety and procedure efficiency | Manuel Gutiérrez de Ravé | |
| 966-P | Impact of Universal Leukoreduction on Transfusion Reaction Trends: Eight-Year Data from the Taiwan Haemovigilance Network | Huang Jingchun | |
| 980-P | The Clinical Value of HLA-Matched, ABO Major-Compatible Platelet Transfusion | yulin Jiang | |
| 981-P | Audit of Erythrocyte Concentrate Utilization and Transfusion Indications at Clinical Hospital Shtip: Toward Implementation of Patient Blood Management | MERI SHOROVA | |
| 989-P | EFFECTIVENESS OF INTRAVENOUS IRON UTILIZATION AT A SINGLE HOSPITAL SETTING | Nur Aklina | |
| 991-P | COVID-19 Restrictions Reinforced PBM-Aligned Blood Ordering Behavior: A Whole-Hospital BBIS Cohort Study from a Malaysian Tertiary Hospital Hospital Tengku Ampuan Rahimah, Klang, Selangor, Malaysia | arif azhar | |
| 1011-P | Transfusion practices in cardiac surgery patients: a single-center study (2021–2022) | NTOUKOLI ANASTASIA &913;&925;&913;&931;&932;&913;&931;&921;&913; | |
| 1023-P | IMPORTANCE OF ANTENATAL SCREENING IN EARLY DETECTION OF PARTIAL D VARIANT AMONG INDIGENOUS PENAN PREGNANT WOMEN | Nur Aklina | |
| 1037-P | Monitoring of biochemical and hematological parameters in 93 transfused patients at the University Clinics of Bukavu (C.U.B) and at the Salama Polyclinic (P.S), East of the DRC. | Promesse Muhubao Bahati | |
| 1043-P | Standardising Cellular Banking, Histocompatibility Use, and Storage-Lesion Monitoring to Improve Transfusion Safety and Cell-Product Quality | SUVAM BANERJEE | |
| 1046-P | Optimization of Hematopoietic Stem Cell Storage and Cryobank Capacity Management in a High-Volume Transplant Center | Andrei Kolesov | |
| 1049-P | RBC DEPLETION IN MAJOR ABO-INCOMPATIBLE PERIPHERAL BLOOD STEM CELL TRANSPLANTS USING MODIFIED HYDROXYETHYL STARCH PROTOCOL | Amit Ajay Pawar | |
| 1058-P | Evaluation of CD34+ Stem Cell Collection and Engraftment Efficiency (2024 Audit) | Pabasara Premarathne | |
| 1059-P | Peripheral blood stem cell apheresis in low-weight pediatric patients (< 15kg). | ALIAKSEI LIPNITSKI | |
| 1062-P | Establishing a National Peripheral Blood Stem Cell Collection Program for Autologous Transplantation in Montenegro: First-Year Experience | Tamara Šcepanovic | |
| 1071-P | Developing a low-cost platelet-rich-plasma (PRP) protocol treatment for wound healing in resource constrained areas: Case of Cameroon | BEUKOU FONKOU HYGIN STEVE | |
| 1093-P | Transfusion-Induced Immune Response Modulates Cuproptosis via SPP1 in Cholangiocarcinoma | Zhaohui Tang | |
| 1104-P | Distinct ABO Blood Group–Associated Chromatin Signatures in Hematopoietic Stem Cells | Romy Kronstein-Wiedemann | |
| 1111-P | Teletransfusiology as a means of communication with remote regions in conditions of a shortage of specialists | Irina Krobinets | |
| 1112-P | Automated Blood Bank Data Extraction Using RPA | Zuraini Arsad | |
| 1115-P | Challenges in Implementing the ISBT 128 Standard in Low- and Middle-Income Countries | Shivanand Hemant Kumatagi | |
| 1122-P | Data connectivity to monitor key performance indicators and operator productivity in whole blood automation processing | Manuel Gutiérrez de Ravé | |
| 1126-P | Real World Evidence on the prevalence of immunosuppression and liver disease in blood transfusion recipients | Igor Rossa-Ramm | |
| 1133-P | Formation of a dataset for training prognostic AI models in blood donation based on standardized donor data | Irina Krobinets | |
| 1140-P | Using artificial intelligence as a cognitive assistant to plan and execute a transfusion medicine conference | ARUN V J | |
| 1142-P | Implementing an AI Assistant to Streamline Bloodbank administrative guidance and knowledge management: A Pilot Study | Muhammad Faizal Bin Sahari | |
20-24 June, 2026 Kuala Lumpur

Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress. |
||||
|
|